Hot Watch List: Teva Pharmaceutical Industries (NYSE:TEVA), Vodafone Group (NASDAQ:VOD), VIVUS (NASDAQ:VVUS), ConocoPhillips (NYSE:COP), BP plc (ADR) (NYSE:BP)

Teva Pharmaceutical Industries Ltd. (ADR) (NYSE:TEVA) announced that the U.S. Court of Appeals for the Federal Circuit today upheld a ruling by the U.S. District Court for the District of Delaware finding Bristol-Myers Squibb’s entecavir compound claim of U.S. Patent No. 5,206,244 invalid. Teva’s ANDA for entecavir has received tentative approval from the U.S. Food and Drug Administration (FDA). Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) … Continue reading Hot Watch List: Teva Pharmaceutical Industries (NYSE:TEVA), Vodafone Group (NASDAQ:VOD), VIVUS (NASDAQ:VVUS), ConocoPhillips (NYSE:COP), BP plc (ADR) (NYSE:BP)

News Buzz: Teva Pharmaceutical Industries (NYSE:TEVA), World Acceptance (NASDAQ:WRLD), AngioDynamics (NASDAQ:ANGO), The Boeing Company (NYSE:BA)

Pfizer and GlaxoSmithKline are among pharmaceutical companies whose shares advanced after announcing $115 billion of acquisition plans since the end of March. “It’s been like a game of Pac-Man,” said Timothy Chiang, an analyst at CRT Capital Group. Mylan has attempted to negotiate a takeover of Meda, while Chiang said Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has everyone wondering whether it’s going to seek a … Continue reading News Buzz: Teva Pharmaceutical Industries (NYSE:TEVA), World Acceptance (NASDAQ:WRLD), AngioDynamics (NASDAQ:ANGO), The Boeing Company (NYSE:BA)

Drug Stocks In News: Teva Pharmaceutical Industries (NYSE:TEVA), Allergan (NYSE:AGN), Dynavax Technologies Corporation (NASDAQ:DVAX), ISIS Pharmaceuticals (NASDAQ:ISIS)

Teva Pharmaceutical Industries Ltd. (ADR) (NYSE:TEVA) announces the launch of the generic equivalent to Lunesta(R) (Eszopiclone Tablets, CIV), 1, 2 and 3 mg, in the United States. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) stock performance was -0.68% in last session and finished the day at $49.61. Traded volume was 2,806.00million shares in the last session and the average volume of the stock remained 7.21million shares. … Continue reading Drug Stocks In News: Teva Pharmaceutical Industries (NYSE:TEVA), Allergan (NYSE:AGN), Dynavax Technologies Corporation (NASDAQ:DVAX), ISIS Pharmaceuticals (NASDAQ:ISIS)

Healthcare Most Active Stocks: Teva Pharmaceutical Industries (NYSE:TEVA), Johnson & Johnson (NYSE:JNJ), MannKind Corporation (NASDAQ:MNKD), Abbott Laboratories (NYSE:ABT)

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) is one of half a dozen drugmakers that have been rolling out generics of Eli Lilly’s ($LLY) top-selling blockbuster Cymbalta. The others are going to roll past the Israeli drugmaker after it recalled more than 1 million bottles of the antidepressant. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) stock performance was -0.76% in last session and finished the day at … Continue reading Healthcare Most Active Stocks: Teva Pharmaceutical Industries (NYSE:TEVA), Johnson & Johnson (NYSE:JNJ), MannKind Corporation (NASDAQ:MNKD), Abbott Laboratories (NYSE:ABT)

FB Nasdaq FB Facebook

Drug Manufacturer Stocks: Teva Pharmaceutical Industries (NYSE:TEVA), Prana Biotechnology (NASDAQ:PRAN), Amarin Corporation (NASDAQ:AMRN), Depomed Inc (NASDAQ:DEPO)

National Alliance Securities assumed coverage on shares of Teva Pharmaceutical Industries Ltd (ADR) (NASDAQ:TEVA) in a research note issued to investors on Monday, Analyst Ratings Netreports. The firm issued a buy rating and a $64.22 price target on the stock. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) stock performance was -1.18% in last session and finished the day at $50.90. Traded volume was 500.00million shares in … Continue reading Drug Manufacturer Stocks: Teva Pharmaceutical Industries (NYSE:TEVA), Prana Biotechnology (NASDAQ:PRAN), Amarin Corporation (NASDAQ:AMRN), Depomed Inc (NASDAQ:DEPO)

Healthcare Most Active Stocks: Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Teva Pharmaceutical Industries (NYSE:TEVA), Bristol-Myers Squibb (NYSE:BMY)

During the trial, palbociclib — a pill — was combined with the standard anti-estrogen treatment Letrozole. The combined treatment resulted in a 26.1 month progression-free survival rate compared with only 7.5 months for Letrozole alone. Under development by Pfizer Inc. (NYSE:PFE), the medication used in the study is a selective inhibitor of cyclin-dependent kinases (CDK) 4 and 6. Pfizer Inc. (NYSE:PFE) stock performance was -1.06% … Continue reading Healthcare Most Active Stocks: Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Teva Pharmaceutical Industries (NYSE:TEVA), Bristol-Myers Squibb (NYSE:BMY)